What is the main purpose of using anti-platelet therapy in cardiac patients?

The main purpose of using anti-platelet therapy in cardiac patients is to prevent thrombosis and reduce the risk of heart attack or stroke. This therapy works by inhibiting platelet aggregation, which is a crucial step in the formation of blood clots. In cardiac patients, especially those with a history of coronary artery disease, there is an increased risk of thrombus formation that can lead to acute coronary events.

By using anti-platelet agents, healthcare providers aim to minimize the chance of clot formation within the arteries that supply blood to the heart and brain. This helps to maintain blood flow and prevent ischemic events, such as myocardial infarction (heart attack) and cerebrovascular accidents (strokes).

While controlling cholesterol levels, heart rate, and improving blood circulation are important aspects of overall cardiovascular care, they are not the primary function of anti-platelet therapies. The focus is specifically on mitigating the risks associated with thrombosis by preventing platelets from clumping together and forming clots that could obstruct blood vessels.